Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance

Medical Oncology

Volumn 31, Issue 7, 2014, Pages

  Lin, Xinxiu ^a   Yang, Man ^a   Xia, Tian ^a   Guo, Junming ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

ABHD11 AS1; Gastric cancer; Long noncoding RNAs; Tumor marker

Indexed keywords

ABHD11 ANTISENSE RNA 1; CA 19-9 ANTIGEN; COMPLEMENTARY RNA; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER TISSUE; CLINICAL FEATURE; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR DIFFERENTIATION; AGED; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; STOMACH TUMOR;

AGED; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; RNA, LONG NONCODING; ROC CURVE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901889493     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0042-4     Document Type: Article

References (18)

1. Ferlay J, Shin Hai-Rim, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;217:2893-917.
2. Bu Z, Ji J. Therapeutic implications of mTOR inhibitors in the treatment of gastric cancer. Curr Cancer Drug Targets. 2013;13:121-5.
3. Song H, Sun W, Ye G, et al. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med. 2013;11:225.
4. Hauptman N, Glavač D. Long non-coding RNA in cancer. Int J Mol Sci. 2013;14:4655-69.
5. Crea F, Watahiki A, Quagliata L, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 2014;5:764-74.
6. Ono H, Motoi N, Nagano H, Miyauchi E, Ushijima M, Matsuura M, et al. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med. 2014;. doi:10.1002/cam4.220.
7. Zhang J, Han L, Bao Z, et al. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol. 2013;15:1595-603.
8. Mei D, Song H, Wang K, et al. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med Oncol. 2013;30:709.
9. Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013;26:155-65.
10. Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase. Nat Med. 2008;14:723-30.
11. Lac atena RM, Cesareni G. Base pairing of RNA I with its complementary sequence in the primer precursor inhibits ColE1 replication. Nature. 1981;294:623-6.
12. Tomizawa J, Itoh T, Selzer G, et al. Inhibition of ColE1 RNA primer formation by a plasmid-specified small RNA. Proc Natl Acad Sci USA. 1981;78:1421-5.
13. Simons RW, Kleckner N. Biological regulation by antisense RNA in prokaryotes. Annua Rev Genet. 1988;22:567-600.
14. Sun W, Wu Y, Yu X, et al. Decreased expression of long noncoding RNA AC096655. 1-002 in gastric cancer and its clinical significance. Tumor Biol. 2013;34:2697-701.
15. Zhao J, Ohsumi TK, Kung JT, et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol Cell. 2010;40:939-53.
16. Pang Q, Ge J, Shao Y, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumor Biol. 2014. doi:10.1007/s13277-014-1709-3.
17. Halley P, Khorkova O, Wahlestedt C. Natural antisense transcripts as therapeutic targets. Drug Discov Today Ther Strateg. 2013. doi:10.1016/j.Ddstr. 2013.03.001.
18. Wahlestedt C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov Today. 2006;11:503-8.